Literature DB >> 2665977

In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

S Makonkawkeyoon1, W Kasinrerk.   

Abstract

The suppressive activity of three different lots and sources of Mycobacterium leprae (M. leprae) was studied by measuring the inhibitory effect on interleukin 2 (IL-2) production in normal subjects. All three M. leprae preparations had suppressive activity on IL-2 production when peripheral blood mononuclear leucocytes (PBML) were stimulated with the mitogens PHA-P or Con A in a dose response. M. leprae also had suppressive activity on IL-2 production when PBML were stimulated with the specific antigen, PPD. The inhibitory activity of M. leprae on IL-2 was not due to the direct interaction of M. leprae and IL-2 because direct mixing of IL-2 with different concentrations of M. leprae did not alter the activity of IL-2. Incorporation of M. leprae for 0, 6 and 12 h in PHA-P and PBML cultures had no inhibitory effect on IL-2 production; however, after 14, 16 and 18 h of M. leprae incorporation, significant inhibitory effects were noted on IL-2 production. The suppressive mechanism of M. leprae was studied by incorporating M. leprae into PBML or adherent cells. The suppressive activity could be detected in both M. leprae-stimulated PBML and M. leprae-stimulated monocyte supernatant fluids. The suppressive mechanism of M. leprae was further evaluated by incorporating 1 and 2 micrograms/ml of indomethacin in PBML containing PHA-P and M. leprae. The suppressive activity of M. leprae was significantly diminished by indomethacin, suggesting that the inhibitory effect of M. leprae may result from the induction of PBML and adherent cells to produce the immunosuppressive activity of prostaglandin(s).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665977      PMCID: PMC1541890     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Lepromin-induced suppressor cells in patients with leprosy.

Authors:  V Mehra; L H Mason; J P Fields; B R Bloom
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 4.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

5.  Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.

Authors:  G L Stoner; R N Mshana; J Touw; A Belehu
Journal:  Scand J Immunol       Date:  1982-01       Impact factor: 3.487

6.  Enumeration of interleukin 2-producing cells from rat spleen.

Authors:  S Makonkawkeyoon; C Hirunpetcharat; W Kasinrerk; V Vithayasai
Journal:  Asian Pac J Allergy Immunol       Date:  1987-12       Impact factor: 2.310

7.  Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.

Authors:  W E Bullock; S Watson; K E Nelson; V Schauf; S Makonkawkeyoon; R R Jacobson
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.

Authors:  V Mehra; L H Mason; W Rothman; E Reinherz; S F Schlossman; B R Bloom
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.

Authors:  A Granelli-Piperno; J D Vassalli; E Reich
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.

Authors:  H K Prasad; R S Mishra; I Nath
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  4 in total

1.  Effects of essential fatty acid deficiency on prostaglandin E2 production and cell-mediated immunity in a mouse model of leprosy.

Authors:  L B Adams; T P Gillis; D H Hwang; J L Krahenbuhl
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

2.  Early accumulation of suppressor cell precursors in the spleen of Mycobacterium lepraemurium-infected mice and analysis of their in vitro-induced maturation.

Authors:  S Lemieux; D Gosselin; Y Lusignan; R Turcotte
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

3.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen.

Authors:  C S Chujor; B Kuhn; B Schwerer; H Bernheimer; W R Levis; D Bevec
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.